Clinical Trials Directory

Trials / Conditions / Juvenile Dermatomyositis

Juvenile Dermatomyositis

21 registered clinical trials studyying Juvenile Dermatomyositis — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingDescartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
NCT07089121
Cartesian TherapeuticsPhase 1 / Phase 2
RecruitingMIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
NCT07374107
Myositis International Health & Research Collaborative Alliance Foundation—
CompletedComparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children
NCT07138157
Istanbul University - CerrahpasaN/A
CompletedFitness Integrative Training for Pediatric Rheumatology Disorders
NCT06556992
Children's Hospital Medical Center, CincinnatiN/A
RecruitingClinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
NCT06569472
Chongqing Precision Biotech Co., LtdPhase 1
RecruitingRESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Id
NCT06154252
Cabaletta BioPhase 2 / Phase 3
CompletedBaricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
NCT05524311
Assistance Publique - Hôpitaux de ParisPhase 2
CompletedTransition to Adulthood Through Coaching and Empowerment in Rheumatology
NCT05545839
McMaster UniversityN/A
UnknownJuvenile Dermatomyositis
NCT03433638
University Hospital, Strasbourg, France—
UnknownIncidence and Prevalence of Juvenile Dermatomyositis
NCT03432455
University Hospital, Strasbourg, France—
CompletedYellow Fever Vaccine in Patients With Rheumatic Diseases
NCT03430388
University of Sao Paulo General HospitalN/A
CompletedEfficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyos
NCT02245841
The Cleveland ClinicPhase 4
CompletedThe Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
NCT02267005
The Hospital for Sick ChildrenN/A
CompletedClinical Analysis of Juvenile Dermatomyositis Patients
NCT05509140
The First Hospital of Jilin University—
RecruitingEnvironmental Risk Factors for the Anti-synthetase Syndrome
NCT01276470
National Institute of Environmental Health Sciences (NIEHS)—
UnknownCreatine Supplementation in Pediatric Rheumatology
NCT01217320
University of Sao PauloN/A
CompletedThe CARRA Registry
NCT01697254
Duke University—
CompletedImmune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
NCT00815282
N.M. WulffraatPhase 4
CompletedFive-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
NCT00323960
Istituto Giannina GasliniPhase 3
CompletedRituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
NCT00106184
University of PittsburghPhase 2
RecruitingStudies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Derm
NCT00059748
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)—